Daito Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
May'26
May'25
May'24
May'23
May'22
May'21
No of Months
12
12
12
12
12
12
Profit Before Tax
4,065.00
2,958.00
4,218.00
5,076.00
6,720.00
5,873.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
1,969.00
-540.00
-1,174.00
-2,457.00
-3,703.00
-2,041.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
9,377.00
5,897.00
5,182.00
4,155.00
4,370.00
5,182.00
Cash Flow from Investing Activities
-4,388.00
-7,365.00
-5,930.00
-5,566.00
-4,332.00
-6,324.00
Cash Flow from Financing Activities
-6,289.00
1,002.00
-183.00
616.00
921.00
1,424.00
Net Cash Inflow / Outflow
-1,253.00
-520.00
-880.00
-775.00
1,007.00
288.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
47.00
-54.00
51.00
20.00
48.00
5.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Daito Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
4065
-4291.743
8,356.00
194.72%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
1969
-132.475
2,101.00
1586.32%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
9377
-3805.485
13,182.00
346.41%
Cash Flow from Investing Activities
-4388
-231.044
-4,157.00
-1799.21%
Cash Flow from Financing Activities
-6289
16007.285
-22,296.00
-139.29%
Net Cash Inflow / Outflow
-1253
11962.142
-13,215.00
-110.47%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
47
-8.614
55.00
645.62%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - May'26
YoY Growth in year ended May 2026 is 59.01% vs 13.80% in May 2025
May'26
May'25
Change(%)
Cash Flow from Operating Activities
9,377.00
5,897.00
59.01%
Footer loading






